| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), BBOT's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 4.53M | $42.25M | - | |
| CEO | 1.11M | $10.40M | - | |
| Dir | 138.2K | $1.29M | - | |
| Dir | 91.1K | $849.7K | - | |
| Dir | 63.4K | $591.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2024 | Chen Bihua56 | CEO And Chairperson | Buy | 2,400,000 | $10.00 | $24,000,000.00 | New | -0.3% | +3.2% |